title: ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
authors.affiliation: Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona. m.offidani@ospedaliriuniti.marche.it
authors.forename: Massimo
authors.initials: M
authors.lastname: Offidani
authors.forename: Pietro
authors.initials: P
authors.lastname: Leoni
authors.forename: Laura
authors.initials: L
authors.lastname: Corvatta
authors.forename: Claudia
authors.initials: C
authors.lastname: Polloni
authors.forename: Silvia
authors.initials: S
authors.lastname: Gentili
authors.forename: Agnese
authors.initials: A
authors.lastname: Savini
authors.forename: Francesco
authors.initials: F
authors.lastname: Alesiani
authors.forename: Marino
authors.initials: M
authors.lastname: Brunori
authors.forename: Massimo
authors.initials: M
authors.lastname: Catarini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Visani
authors.forename: Arduino
authors.initials: A
authors.lastname: Samori
authors.forename: Maurizio
authors.initials: M
authors.lastname: Burattini
authors.forename: Riccardo
authors.initials: R
authors.lastname: Centurioni
authors.forename: Mauro
authors.initials: M
authors.lastname: Montanari
authors.forename: Paolo
authors.initials: P
authors.lastname: Fraticelli
authors.forename: Miriana
authors.initials: M
authors.lastname: Ruggieri
authors.forename: Sadia
authors.initials: S
authors.lastname: Falcioni
authors.forename: Piero
authors.initials: P
authors.lastname: Galieni